round button
Leave a message

全球醛糖还原酶抑制剂市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球醛糖还原酶抑制剂市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Aldose Reductase Inhibitor Market

市场规模(十亿美元)

CAGR :  % Diagram

Chart Image USD 6.71 Billion USD 10.70 Billion 2023 2030
Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 6.71 Billion
Diagram Market Size (Forecast Year)
USD 10.70 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球醛糖还原酶抑制剂市场,按作用部位(神经组织、视网膜、肾脏、心血管等)、药物(羧酸衍生物、螺内酰脲和环酰胺、酚类衍生物等)、给药途径(口服、肠胃外、其他)、最终用户(医院、家庭护理、专科诊所、其他)、分销渠道(医院药房、网上药房、零售药房)划分 - 行业趋势和预测到 2030 年。

醛糖还原酶抑制剂市场

醛糖还原酶抑制剂市场分析和规模

糖尿病病例的增加推动了醛糖还原酶抑制剂市场的发展。糖尿病的发病率与葡萄糖生理水平的巨大变化有关,并且常常与许多长期并发症有关,例如肾病、视网膜病变、神经病变、白内障和心血管疾病。不健康生活方式的适应性增加以及代谢和一般疾病的增加增加了患糖尿病的风险,这也推动了醛糖还原酶抑制剂市场的增长。

Data Bridge Market Research 分析了 2023-2030 年预测期内醛糖还原酶抑制剂市场的增长率。在上述预测期内,醛糖还原酶抑制剂市场的预期复合年增长率趋于 6% 左右。2022 年市场价值为 67.1 亿美元,到 2030 年将增长至 107 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

醛糖还原酶抑制剂的市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

作用部位(神经组织、视网膜、肾脏、心血管等)、药物(羧酸衍生物、螺环己内酰脲和环酰胺、酚类衍生物等)、给药途径(口服、肠胃外等)、最终用户(医院、家庭护理、专科诊所等)、分销渠道(医院药房、网上药房、零售药房)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

YZJ Group (China), Therapeutic Vision, Inc (India), Pierre Fabre Group (France)

Market Opportunities

  • Increasing Incidence of Foot Ulcers
  • Increasing Demand for Retail Pharmacies

Market Definition

Aldose reductase is an aldo-keto reductase super family enzyme catalyzes the conversion of glucose to sorbitol in polyol pathways of glucose metabolism. Contrastingly, the aldose reductase inhibitor declines the flux of sorbitol through polyol pathways. This inhibitor developed vary structurally, and representative structural classes which includes carboxylic acid derivatives such as Epalrestat, Alrestatin, Zopalrestat, Zenarestat, Ponalrestat, Lidorestat, and Tolrestat, then spirohydantoins and related cyclic amides and lastly phenolic derivatives

Aldose Reductase Inhibitor Market Dynamics

Drivers

  • Increasing Incidence of Peripheral Neuropathy

Peripheral neuropathy is a very common complication of diabetes mellitus. Records of the incidence of neuropathy in people suffering from diabetes vary from 10 to 50%, depending on several factors such as how neuropathy is defined, methods of detection, and the population studied. A latest review states that neuropathy is available in around 30% of people attending hospital diabetes clinics, 20% of people with diabetes in primary care settings and 10% of the entire population of patients with diabetes. Furthermore, longitudinal studies of people with diabetic polyneuropathy have showed that their clinical and electrophysiological abnormalities degrade with time, although slowly. The trials used various measures to look for a benefit of treatment with aldose reductase inhibitors. Therefore, this factor boosts the market growth.  

Opportunities

  • Increasing Incidence of Foot Ulcers

The global incidence of foot ulcers in all people with diabetes is around 1%, but in those with known sensory loss from neuropathy, the occurrence is seven times higher. Furthermore, non‐healing foot ulcers follow the large majority of amputations in people suffering from diabetes, and diabetic polyneuropathy is related with a 2 to 25 fold increase in the risk of amputation. Thus, this rising prevalence of foot ulcers is surely boosting the growth of the market.

  • Growing Demand for Retail Pharmacies

The rise in the number of aldose reductase inhibitor being supplied through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. Additionally, patients favour retail pharmacies for purchasing drugs, as these are easily available and accessible.

 Restraints/Challenges

  • Side Effect of Treatment

There are adverse effects that are visible in patients with these inhibitors, except for extreme allergic reactions with sorbinil, impaired kidney function with zenarestat, and alteration of liver function with tolrestat. Thus, these restrain the market growth.

  • High Cost of Treatment

与药物相关的支出不断增长阻碍了市场的增长。这些抑制剂成本高昂,并且不发达国家的人们负担不起,导致许多患者得不到治疗。这阻碍了市场的增长。

本醛糖还原酶抑制剂市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关醛糖还原酶抑制剂市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

全球醛糖还原酶抑制剂市场范围

醛糖还原酶抑制剂市场根据作用位点、药物、给药途径、分销渠道和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

行动地点

  • 神经组织
  • 视网膜
  • 心血管
  • 其他的

药品

  • 羧酸衍生物
  • 螺环乙内酰脲和环状酰胺
  • 酚类衍生物
  • 其他的

给药途径

  • 口服
  • 肠外
  • 其他的

最终用户

  • 医院
  • 家庭护理
  • 专科诊所
  • 其他的

分销渠道

  • 医院药房
  • 网上药店
  • 零售药店

醛糖还原酶抑制剂市场区域分析/见解

对醛糖还原酶抑制剂市场进行了分析,并按作用部位、药物、给药途径、分销渠道和最终用户提供了市场规模洞察和趋势。

醛糖还原酶抑制剂市场报告涉及的主要国家 有:北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区(APAC)的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区(APAC)的其他地区、中东和非洲(MEA)的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美醛糖还原酶抑制剂市场在整个预测期内一直呈现正增长态势,这是因为医疗保健和研发支出不断增长,患者意识增强,主要市场参与者对新技术或现有药物配方的了解对醛糖还原酶抑制剂市场的增长发挥了重要作用。此外,随着医疗保健领域支出的增加,欧洲被认为将在未来几年实现巨大的增长前景。

亚太地区因糖尿病及相关疾病发病率高且仿制药数量众多而占据市场主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。 

竞争格局和全球醛糖还原酶抑制剂市场份额分析

醛糖还原酶抑制剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对醛糖还原酶抑制剂市场的关注有关。

醛糖还原酶抑制剂市场的主要参与者包括:

  • 扬子江集团(中国)
  • Therapeutic Vision, Inc(印度)
  • 皮尔法伯集团(法国)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The aldose reductase inhibitor market was USD 6.71 billion in 2022.
The aldose reductase inhibitor market is projected to grow at a CAGR of 6% during the forecast period of 2023-2030.
The Aldose Reductase Inhibitor Market report is analyzed on the basis of action, drug, route of administration, distribution channel, and end-user.
Asia-Pacific dominates the market because of the high occurrence cases of diabetes and related disorders and a number of generic drugs.
Testimonial
a